Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (2)

2023

  1. Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

    Current Medical Research and Opinion, Vol. 39, Núm. 10, pp. 1395-1405

2022

  1. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain

    Chest, Vol. 162, Núm. 5, pp. 1017-1029